Cybrexa press releases
Web2 days ago · NEW HAVEN, Apr 12, 2024 (GLOBE NEWSWIRE via COMTEX) -- NEW HAVEN, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical … WebNew Haven, Conn., January 9, 2024 – Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ tumor targeting platform, today announced CBX-12 (alphalex TM -exatecan) as the new lead development program.
Cybrexa press releases
Did you know?
WebOct 28, 2024 · NEW HAVEN, Conn., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class … WebDec 15, 2024 · Cybrexa appoints Jaya Gautam as SVP of technical operations. 13-04-2024. US clinical-stage oncology biotech Cybrexa Therapeutics has appointed Jaya Gautam as senior vice president, technical operations. ... For editorial enquiries, press releases and events please email [email protected]
WebNEW HAVEN, Conn., Feb. 01, 2024 (GLOBE NEWSWIRE) — Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor … initial development focus: toxin conjugates. Highly potent anti-cancer agents that are … © 2024 Cybrexa All Rights Reserved Dr. Houston is President and Chief Executive Officer of Arvinas, Inc. … November 01, 2024 04:06 PM Eastern Daylight Time – ALAMEDA, Calif. & … How. By using technology that allows small molecule anti-cancer agents to … latest news. We are passionate about how alphalex™ can improve cancer … Board of Directors - Press Releases Archive - Cybrexa Therapeutics Management Team - Press Releases Archive - Cybrexa Therapeutics Scientific Advisors - Press Releases Archive - Cybrexa Therapeutics WebNov 1, 2024 · This press release contains forward-looking statements, including, without limitation, statements related to: the therapeutic potential of CBX-12 to improve efficacy and reduce toxicity over systemic topoisomerase inhibitors; the potential for CBX-12 to be a first-in-class PDC of exatecan, with broad utility in patients with diverse tumor types …
WebJun 8, 2024 · Cybrexa is a privately-held biotechnology company dedicated to developing next-generation tumor-targeted cancer therapies using its alphalex™ platform. The Company’s lead candidate, CBX-12, an... WebOct 28, 2024 · Cybrexa investors include Advantage Capital Connecticut, Connecticut Innovations, Elm Street Ventures and HighCape Capital. It is on a mission to create therapeutics that revolutionize the standard of care in oncology. Cybrexa’s robust pipeline aims to combat breast, ovarian, non-small cell lung cancer and a range of other tumors.
Web1 day ago · 13-04-2024 Print. US clinical-stage oncology biotech Cybrexa Therapeutics has appointed Jaya Gautam as senior vice president, technical operations. Dr Gautam joins …
WebFeb 1, 2024 · NEW HAVEN, Conn., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC ... asian baseball playersWebAug 26, 2024 · Aug 26, 2024, 07:00 ET NEW YORK, Aug. 26, 2024 /PRNewswire/ -- Phosplatin Therapeutics LLC, a clinical stage pharmaceutical company focused on oncology therapeutics, today announced the completion... aswc wiring diagramWebfox8.com aswd unspeakableWebNov 1, 2024 · Exelixis, Inc. (Nasdaq: EXEL) and Cybrexa Therapeutics (Cybrexa) today announced that the companies have entered into an exclusive collaboration agreement … asian baseWebNov 1, 2024 · ALAMEDA, Calif. & NEW HAVEN, Conn.--(BUSINESS WIRE)-- Exelixis, Inc. (Nasdaq: EXEL) and Cybrexa Therapeutics (Cybrexa) today announced that the companies have entered into an exclusive collaboration agreement providing Exelixis the right to acquire CBX-12 (alphalex™ exatecan), a clinical-stage, first-in-class peptide-drug … asian baseball players mlbWebJan 28, 2024 · 关于Cybrexa. Cybrexa是一家私营生物科技公司，致力于利用其alphalex™平台开发新一代肿瘤靶向癌症疗法。. 公司的先导候选物CBX-12（一种alphalex™-exatecan ... asian baseball players in mlb 2021WebApr 12, 2024 · April 12, 2024 8:00 AM 3 min read. NEW HAVEN, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor ... asweerun schuh adidas